Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
COHEN, Ezra E. W, ROSEN, Lee S, TORTORICI, Michael, SHALINSKY, David R, LIAU, Katherine F, COHEN, Roger B, VOKES, Everett E, KIES, Merrill S, FORASTIERE, Arlene A, WARDEN, Francis P, KANE, Madeleine A, SHERMAN, Eric, KIM, Sinil, BYCOTT, Paul
Published in Journal of clinical oncology (10.10.2008)
Published in Journal of clinical oncology (10.10.2008)
Get full text
Journal Article
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
Rixe, Olivier, Prof, Bukowski, Ronald M, MD, Michaelson, M Dror, MD, Wilding, George, MD, Hudes, Gary R, MD, Bolte, Oliver, MD, Motzer, Robert J, MD, Bycott, Paul, DrPH, Liau, Katherine F, BS, Freddo, James, MD, Trask, Peter C, PhD, Kim, Sinil, MD, Rini, Brian I, MD
Published in The lancet oncology (01.11.2007)
Published in The lancet oncology (01.11.2007)
Get full text
Journal Article
Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)
Bokemeyer, Bernd, Hlavaty, Tibor, Allez, Matthieu, Selema, Pamela, Moosavi, Shahrzad, Cadatal, Mary Jane, Fowler, Heather, Mueller, Markus, Liau, Katherine F, Gisbert, Javier P
Published in Expert opinion on biological therapy (03.08.2023)
Published in Expert opinion on biological therapy (03.08.2023)
Get full text
Journal Article
Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
RUGO, Hope S, STOPECK, Alison T, BAIR, Angel H, SOULIERES, Denis, JOY, Anil A, CHAN, Stephen, VERMA, Shailendra, LLUCH, Anna, LIAU, Katherine F, KIM, Sinil, BYCOTT, Paul, ROSBROOK, Brad
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article
Conference Proceeding
Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study
SCHILLER, Joan H, LARSON, Timothy, VON PAWEL, Joachim, IGNATIUS OU, S.-H, LIMENTANI, Steven, SANDLER, Alan, VOKES, Everett, KIM, Sinil, LIAU, Katherine, BYCOTT, Paul, OLSZANSKI, Anthony J
Published in Journal of clinical oncology (10.08.2009)
Published in Journal of clinical oncology (10.08.2009)
Get full text
Journal Article
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
Spano, Jean-Philippe, Prof, Chodkiewicz, Catherine, MD, Maurel, Joan, MD, Wong, Ralph, MD, Wasan, Harpreet, MD, Barone, Carlo, Prof, Létourneau, Richard, MD, Bajetta, Emilio, MD, Pithavala, Yazdi, PhD, Bycott, Paul, DrPh, Trask, Peter, PhD, Liau, Katherine, BS, Ricart, Alejandro D, MD, Kim, Sinil, MD, Rixe, Olivier, Prof
Published in The Lancet (British edition) (21.06.2008)
Published in The Lancet (British edition) (21.06.2008)
Get full text
Journal Article
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study
DeAngelo, Daniel J., Stock, Wendy, Stein, Anthony S., Shustov, Andrei, Liedtke, Michaela, Schiffer, Charles A., Vandendries, Erik, Liau, Katherine, Ananthakrishnan, Revathi, Boni, Joseph, Laird, A. Douglas, Fostvedt, Luke, Kantarjian, Hagop M., Advani, Anjali S.
Published in Blood advances (27.06.2017)
Published in Blood advances (27.06.2017)
Get full text
Journal Article
Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
Robert, Nicholas J, Saleh, Mansoor N, Paul, Devchand, Generali, Daniele, Gressot, Laurent, Copur, Mehmet S, Brufsky, Adam M, Minton, Susan E, Giguere, Jeffrey K, Smith, John W, Richards, Paul D, Gernhardt, Diana, Huang, Xin, Liau, Katherine F, Kern, Kenneth A, Davis, John
Published in Clinical breast cancer (01.04.2011)
Published in Clinical breast cancer (01.04.2011)
Get full text
Journal Article
A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
SWEENEY, Christopher J, CHIOREAN, E. Gabriela, BURRIS, Howard A, VERSCHRAEGEN, Claire F, FA CHYI LEE, JONES, Suzanne, ROYCE, Melanie, TYE, Lesley, LIAU, Katherine F, BELLO, Akintunde, CHAO, Richard
Published in Journal of clinical oncology (10.10.2010)
Published in Journal of clinical oncology (10.10.2010)
Get full text
Journal Article
Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)
Taylor, Peter C, Christensen, Robin, Moosavi, Shahrzad, Selema, Pamela, Guilatco, Ruffy, Fowler, Heather, Mueller, Markus, Liau, Katherine F, Haraoui, Boulos
Published in Rheumatology advances in practice (01.01.2021)
Published in Rheumatology advances in practice (01.01.2021)
Get full text
Journal Article
PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study
Reinmuth, Niels, Bryl, Maciej, Bondarenko, Igor, Syrigos, Kostas, Vladimirov, Vladimir, Zereu, Manuela, Bair, Angel H., Hilton, Fiona, Liau, Katherine, Kasahara, Kazuo
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.10.2019)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.10.2019)
Get full text
Journal Article
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
Thomas, Stephen J., Perez, John L., Lockhart, Stephen P., Hariharan, Subramanian, Kitchin, Nicholas, Bailey, Ruth, Liau, Katherine, Lagkadinou, Eleni, Türeci, Özlem, Şahin, Ugur, Xu, Xia, Koury, Kenneth, Dychter, Samuel S., Lu, Claire, Gentile, Teresa C., Gruber, William C.
Published in Vaccine (01.03.2022)
Published in Vaccine (01.03.2022)
Get full text
Journal Article
Comparison of CD22 Expression between Baseline, End of Treatment, and Relapse Among Patients Treated with Inotuzumab Ozogamicin Who Responded and Subsequently Relapsed in Two Clinical Trials
Kantarjian, Hagop M., Stock, Wendy, Cassaday, Ryan D., DeAngelo, Daniel J., Jabbour, Elias J., O'Brien, Susan M., Stelljes, Matthias, Wang, Tao, Liau, Katherine F, Nguyen, Kevin, Sleight, Barbara, Vandendries, Erik, Neuhof, Alexander, Laird, A. Douglas, Advani, Anjali S.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A comparative clinical study of PF-06439535, a candidate bevacizumab biosimilar, and reference bevacizumab, in patients with advanced non-squamous non-small cell lung cancer
Socinski, Mark A., Von Pawel, Joachim, Kasahara, Kazuo, Bondarenko, Igor, Syrigos, Konstantinos, Vladimirov, Vladimir Ivanovich, Bryl, Maciej, Zereu, Manuela, Bair, A H., Hilton, Fiona, Liau, Katherine Faye, Herbst, Roy S.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A Phase II Study of Weekly Inotuzumab Ozogamicin (InO) in Adult Patients with CD22-Positive Acute Lymphoblastic Leukemia (ALL) in Second or Later Salvage
Advani, Anjali S., Stein, Anthony S., Kantarjian, Hagop M., Shustov, Andrei R., DeAngelo, Daniel J., Ananthakrishnan, Revathi, Liau, Katherine, Vandendries, Erik, Stock, Wendy
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Weekly Inotuzumab Ozogamicin (InO) In Adult Patients With Relapsed Or Refractory CD22-Positive Acute Lymphoblastic Leukemia (ALL)
DeAngelo, Daniel J., Stock, Wendy, Shustov, Andrei R., Liedtke, Michaela, Schiffer, Charles A., Ananthakrishnan, Revathi, Boni, Joseph P., Luu, Kenneth, Liau, Katherine, Vandendries, Erik, Advani, Anjali S.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Multicenter, Phase II Study of Axitinib, a Selective SecondGeneration Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, and 3, in Patients with Metastatic Melanoma
FRUEHAUF, John, LUTZKY, Jose, RIXE, Olivier, MCDERMOTT, David, BROWN, Charles K, MERIC, Jean-Baptiste, ROSBROOK, Brad, SHALINSKY, David R, LIAU, Katherine F, NIETHAMMER, Andreas G, KIM, Sinil
Published in Clinical cancer research (2011)
Get full text
Published in Clinical cancer research (2011)
Journal Article
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)
COHEN, Roger B, LANGER, Corey J, HEALEY, Diane, RAJAN SIMON, George, EISENBERG, Peter David, HAINSWORTH, John Daniel, MADAJEWICZ, Stefan, COSGRIFF, Thomas Michael, PIERCE, Kristen, HUIPING XU, LIAU, Katherine
Published in Cancer chemotherapy and pharmacology (01.06.2007)
Published in Cancer chemotherapy and pharmacology (01.06.2007)
Get full text
Journal Article
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer : an open-label randomised phase II study. Commentary
PHILIP, Philip A, SPANO, Jean-Philippe, BYCOTT, Paul, TRASK, Peter, LIAU, Katherine, RICART, Alejandro D, KIM, Sinil, RIXE, Olivier, CHODKIEWICZ, Catherine, MAUREL, Joan, WONG, Ralph, WASAN, Harpreet, BARONE, Carlo, LETOURNEAU, Richard, BAJETTA, Emilio, PITHAVALA, Yazdi
Published in The Lancet (British edition) (2008)
Get full text
Published in The Lancet (British edition) (2008)
Journal Article